• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Shibata Kaito  柴田 海斗

ORCIDConnect your ORCID iD *help
Researcher Number 00857055
Other IDs
Affiliation (Current) 2025: 信州大学, 医学部附属病院, 薬剤主任
Affiliation (based on the past Project Information) *help 2023 – 2024: 信州大学, 医学部附属病院, 薬剤主任
2022: 信州大学, 医学部附属病院, 薬剤師
2020 – 2021: 浜松医科大学, 医学部附属病院, 薬剤師
Review Section/Research Field
Principal Investigator
Basic Section 47060:Clinical pharmacy-related
Except Principal Investigator
Basic Section 47060:Clinical pharmacy-related
Keywords
Principal Investigator
がん患者 / 臨床効果 / 薬物間相互作用 / 体内動態 / 抗体併用療法 / 血中動態 / 皮膚障害 / フーリエ変換型質量分析計 / 固相化パパイン / N型糖鎖構造解析 … More / 全身倦怠感 / アルブミン / 頭頸部がん / 忍容性 / 血清中濃度 / セツキシマブ / 糖鎖修飾 / 炎症性サイトカイン / がん悪液質 / 薬物動態 / 抗EGFR抗体薬 / がん化学療法 … More
Except Principal Investigator
遺伝子多型 / 悪液質 / がん / 薬物動態 / 薬物代謝酵素 / 炎症性サイトカイン / がん悪液質 / オレキシン受容体拮抗薬 Less
  • Research Projects

    (3 results)
  • Research Products

    (4 results)
  • Co-Researchers

    (1 People)
  •  がん抗体薬併用療法における臨床効果の個人差に着目した薬物間相互作用の定量的解析Principal Investigator

    • Principal Investigator
      柴田 海斗
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 47060:Clinical pharmacy-related
    • Research Institution
      Shinshu University
  •  Investigation of interindividual variability in pharmacokinetics of and clinical responses to orexin receptor antagonists in cancer status

    • Principal Investigator
      内藤 隆文
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 47060:Clinical pharmacy-related
    • Research Institution
      Shinshu University
  •  Investigation of anti-cancer effect of anti-EGFR antibody based on quantitative evaluation of its pharmacokinetics and glycosylation in cancer patientsPrincipal Investigator

    • Principal Investigator
      Shibata Kaito
    • Project Period (FY)
      2020 – 2023
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 47060:Clinical pharmacy-related
    • Research Institution
      Shinshu University
      Hamamatsu University School of Medicine

All 2022 2021

All Journal Article Presentation

  • [Journal Article] Correlations between serum cetuximab and EGFR-related markers, and skin disorders in head and neck cancer patients2021

    • Author(s)
      Shibata Kaito、Naito Takafumi、Hirakawa Satoshi、Suzuki Koji、Hosokawa Seiji、Mineta Hiroyuki、Kawakami Junichi
    • Journal Title

      Cancer Chemotherapy and Pharmacology

      Volume: 87 Issue: 4 Pages: 555-565

    • DOI

      10.1007/s00280-020-04228-4

    • NAID

      120007181706

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K16040, KAKENHI-PROJECT-18K19908
  • [Presentation] 頭頸部がんにおける血清中セツキシマブ濃度と悪液質の進行度および臨床症状の関係解析2022

    • Author(s)
      柴田 海斗,細川 誠二,前川 真人,川上 純一,内藤 隆文
    • Organizer
      第16回次世代を担う若手のための医療薬科学シンポジウム
    • Data Source
      KAKENHI-PROJECT-20K16040
  • [Presentation] 頭頸部がんにおける悪液質の進行度と血清中セツキシマブ濃度および臨床症状との関係解析2021

    • Author(s)
      柴田海斗、内藤隆文、細川誠二、前川真人、川上純一
    • Organizer
      第42回日本臨床薬理学会学術総会
    • Data Source
      KAKENHI-PROJECT-20K16040
  • [Presentation] 頭頸部がん患者におけるセツキシマブの血中濃度に基づく皮膚障害の重症度予測とその症状緩和療法の選択2021

    • Author(s)
      柴田海斗、内藤隆文、平川聡史、細川誠二、峯田周幸、川上純一
    • Organizer
      第14回日本緩和医療薬学会年会
    • Data Source
      KAKENHI-PROJECT-20K16040
  • 1.  内藤 隆文 (80422749)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi